Structure

Physi-Chem Properties

Molecular Weight:  554.2
Volume:  522.48
LogP:  0.708
LogD:  0.129
LogS:  -3.471
# Rotatable Bonds:  9
TPSA:  193.83
# H-Bond Aceptor:  13
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.166
Synthetic Accessibility Score:  4.858
Fsp3:  0.577
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.08
MDCK Permeability:  7.067705882946029e-05
Pgp-inhibitor:  0.016
Pgp-substrate:  0.994
Human Intestinal Absorption (HIA):  0.923
20% Bioavailability (F20%):  0.1
30% Bioavailability (F30%):  0.991

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.112
Plasma Protein Binding (PPB):  42.01625442504883%
Volume Distribution (VD):  0.393
Pgp-substrate:  20.580007553100586%

ADMET: Metabolism

CYP1A2-inhibitor:  0.02
CYP1A2-substrate:  0.188
CYP2C19-inhibitor:  0.018
CYP2C19-substrate:  0.219
CYP2C9-inhibitor:  0.007
CYP2C9-substrate:  0.155
CYP2D6-inhibitor:  0.013
CYP2D6-substrate:  0.15
CYP3A4-inhibitor:  0.181
CYP3A4-substrate:  0.085

ADMET: Excretion

Clearance (CL):  1.682
Half-life (T1/2):  0.679

ADMET: Toxicity

hERG Blockers:  0.195
Human Hepatotoxicity (H-HT):  0.208
Drug-inuced Liver Injury (DILI):  0.142
AMES Toxicity:  0.273
Rat Oral Acute Toxicity:  0.373
Maximum Recommended Daily Dose:  0.92
Skin Sensitization:  0.831
Carcinogencity:  0.885
Eye Corrosion:  0.003
Eye Irritation:  0.025
Respiratory Toxicity:  0.861

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC147224

Natural Product ID:  NPC147224
Common Name*:   6'(3,4-Dimethoxycinnamoyl)Harpagide
IUPAC Name:   [(2R,3S,4S,5R,6S)-6-[[(1R,4aR,5S,7R,7aS)-4a,5,7-trihydroxy-7-methyl-1,5,6,7a-tetrahydrocyclopenta[c]pyran-1-yl]oxy]-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(3,4-dimethoxyphenyl)prop-2-enoate
Synonyms:   6'(3,4-Dimethoxycinnamoyl)Harpagide
Standard InCHIKey:  RCKNZJXQBTVMJV-YHLASNOOSA-N
Standard InCHI:  InChI=1S/C26H34O13/c1-25(32)11-17(27)26(33)8-9-36-24(22(25)26)39-23-21(31)20(30)19(29)16(38-23)12-37-18(28)7-5-13-4-6-14(34-2)15(10-13)35-3/h4-10,16-17,19-24,27,29-33H,11-12H2,1-3H3/b7-5+/t16-,17+,19-,20+,21-,22+,23+,24-,25-,26+/m1/s1
SMILES:  COc1ccc(cc1OC)/C=C/C(=O)OC[C@H]1O[C@@H](O[C@H]2OC=C[C@]3([C@@H]2[C@](C)(O)C[C@@H]3O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL593634
PubChem CID:   45101503
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0004081] Iridoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33377 teucrium chamaedris Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[19674906]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 0.7 n.a. PMID[513967]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 1.0 n.a. PMID[513967]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. Activity = 6.5 n.a. PMID[513967]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 10700.0 nM PMID[513967]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 26500.0 nM PMID[513967]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 33100.0 nM PMID[513967]
NPT1 Others Radical scavenging activity IC50 > 300000.0 nM PMID[513967]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC147224 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9859 High Similarity NPC308178
0.9792 High Similarity NPC269914
0.9792 High Similarity NPC478249
0.9658 High Similarity NPC478241
0.9658 High Similarity NPC229548
0.9658 High Similarity NPC89693
0.9507 High Similarity NPC116104
0.9507 High Similarity NPC263397
0.9507 High Similarity NPC237872
0.9507 High Similarity NPC302286
0.9507 High Similarity NPC88754
0.9463 High Similarity NPC478248
0.9404 High Similarity NPC478265
0.931 High Similarity NPC37838
0.9306 High Similarity NPC478240
0.9247 High Similarity NPC18789
0.9178 High Similarity NPC474234
0.915 High Similarity NPC474936
0.9091 High Similarity NPC49597
0.9085 High Similarity NPC179914
0.9079 High Similarity NPC478266
0.9032 High Similarity NPC476011
0.9032 High Similarity NPC206815
0.8981 High Similarity NPC301910
0.8981 High Similarity NPC130730
0.8966 High Similarity NPC46644
0.894 High Similarity NPC203664
0.8924 High Similarity NPC208818
0.8912 High Similarity NPC184464
0.8912 High Similarity NPC251062
0.8912 High Similarity NPC110063
0.8861 High Similarity NPC282551
0.8828 High Similarity NPC226005
0.8819 High Similarity NPC157554
0.8819 High Similarity NPC37468
0.8776 High Similarity NPC140502
0.8766 High Similarity NPC475484
0.875 High Similarity NPC21956
0.875 High Similarity NPC475379
0.8725 High Similarity NPC476382
0.8725 High Similarity NPC34927
0.8725 High Similarity NPC287615
0.8725 High Similarity NPC216819
0.8725 High Similarity NPC34587
0.8725 High Similarity NPC252292
0.8725 High Similarity NPC262182
0.8725 High Similarity NPC83743
0.8725 High Similarity NPC100998
0.8716 High Similarity NPC186296
0.8716 High Similarity NPC478239
0.8707 High Similarity NPC7518
0.8707 High Similarity NPC154262
0.8707 High Similarity NPC137501
0.8707 High Similarity NPC159387
0.8701 High Similarity NPC478232
0.8699 High Similarity NPC100389
0.8693 High Similarity NPC478268
0.8688 High Similarity NPC286809
0.8684 High Similarity NPC188393
0.8684 High Similarity NPC470934
0.8662 High Similarity NPC138993
0.8658 High Similarity NPC297342
0.8649 High Similarity NPC157816
0.8642 High Similarity NPC470685
0.8639 High Similarity NPC202700
0.8625 High Similarity NPC475621
0.8618 High Similarity NPC478242
0.8609 High Similarity NPC232992
0.8599 High Similarity NPC469384
0.8591 High Similarity NPC475213
0.8591 High Similarity NPC152796
0.8581 High Similarity NPC186406
0.8562 High Similarity NPC117346
0.8562 High Similarity NPC240592
0.8562 High Similarity NPC186418
0.8553 High Similarity NPC201148
0.8553 High Similarity NPC215095
0.8553 High Similarity NPC199311
0.8553 High Similarity NPC28651
0.8553 High Similarity NPC3460
0.8553 High Similarity NPC300262
0.8553 High Similarity NPC80732
0.8553 High Similarity NPC192763
0.8553 High Similarity NPC261122
0.8553 High Similarity NPC210611
0.8543 High Similarity NPC199928
0.8543 High Similarity NPC476865
0.8535 High Similarity NPC286919
0.8535 High Similarity NPC475663
0.8533 High Similarity NPC232228
0.8516 High Similarity NPC469699
0.8503 High Similarity NPC304152
0.85 High Similarity NPC109990
0.8497 Intermediate Similarity NPC94871
0.8497 Intermediate Similarity NPC306890
0.8497 Intermediate Similarity NPC476398
0.8497 Intermediate Similarity NPC283839
0.8497 Intermediate Similarity NPC96599
0.8497 Intermediate Similarity NPC259347
0.8497 Intermediate Similarity NPC478236
0.8497 Intermediate Similarity NPC90896
0.8497 Intermediate Similarity NPC470933
0.8497 Intermediate Similarity NPC476386
0.8497 Intermediate Similarity NPC478234
0.8497 Intermediate Similarity NPC106138
0.8497 Intermediate Similarity NPC473427
0.8497 Intermediate Similarity NPC471062
0.8493 Intermediate Similarity NPC55040
0.8483 Intermediate Similarity NPC25821
0.8483 Intermediate Similarity NPC254398
0.8483 Intermediate Similarity NPC6836
0.8477 Intermediate Similarity NPC476866
0.8477 Intermediate Similarity NPC476869
0.8477 Intermediate Similarity NPC476864
0.8477 Intermediate Similarity NPC476868
0.8472 Intermediate Similarity NPC254819
0.8471 Intermediate Similarity NPC11411
0.8456 Intermediate Similarity NPC472711
0.8452 Intermediate Similarity NPC194705
0.8446 Intermediate Similarity NPC328273
0.8446 Intermediate Similarity NPC321638
0.8446 Intermediate Similarity NPC321184
0.8446 Intermediate Similarity NPC171134
0.8442 Intermediate Similarity NPC69367
0.8442 Intermediate Similarity NPC257970
0.8442 Intermediate Similarity NPC470927
0.8438 Intermediate Similarity NPC145847
0.8431 Intermediate Similarity NPC96294
0.8425 Intermediate Similarity NPC35731
0.8425 Intermediate Similarity NPC471883
0.8425 Intermediate Similarity NPC470881
0.8414 Intermediate Similarity NPC473924
0.8414 Intermediate Similarity NPC473285
0.8414 Intermediate Similarity NPC252833
0.8411 Intermediate Similarity NPC129417
0.8411 Intermediate Similarity NPC283995
0.8411 Intermediate Similarity NPC470235
0.8411 Intermediate Similarity NPC296659
0.8411 Intermediate Similarity NPC202391
0.8411 Intermediate Similarity NPC84181
0.8411 Intermediate Similarity NPC292443
0.8411 Intermediate Similarity NPC476867
0.84 Intermediate Similarity NPC296643
0.8387 Intermediate Similarity NPC7145
0.8387 Intermediate Similarity NPC289021
0.8387 Intermediate Similarity NPC158546
0.8387 Intermediate Similarity NPC85192
0.8387 Intermediate Similarity NPC213197
0.8387 Intermediate Similarity NPC143480
0.8387 Intermediate Similarity NPC125823
0.838 Intermediate Similarity NPC276047
0.838 Intermediate Similarity NPC267733
0.8378 Intermediate Similarity NPC476376
0.8377 Intermediate Similarity NPC111785
0.8367 Intermediate Similarity NPC476870
0.8366 Intermediate Similarity NPC473149
0.8366 Intermediate Similarity NPC41844
0.8366 Intermediate Similarity NPC52740
0.8365 Intermediate Similarity NPC478269
0.8354 Intermediate Similarity NPC228357
0.8345 Intermediate Similarity NPC219677
0.8345 Intermediate Similarity NPC248307
0.8345 Intermediate Similarity NPC475824
0.8345 Intermediate Similarity NPC65942
0.8344 Intermediate Similarity NPC185307
0.8344 Intermediate Similarity NPC477898
0.8344 Intermediate Similarity NPC470950
0.8344 Intermediate Similarity NPC46092
0.8333 Intermediate Similarity NPC289967
0.8333 Intermediate Similarity NPC472611
0.8333 Intermediate Similarity NPC477293
0.8333 Intermediate Similarity NPC470264
0.8333 Intermediate Similarity NPC307110
0.8333 Intermediate Similarity NPC229784
0.8333 Intermediate Similarity NPC477294
0.8333 Intermediate Similarity NPC295970
0.8333 Intermediate Similarity NPC248355
0.8333 Intermediate Similarity NPC134405
0.8333 Intermediate Similarity NPC472612
0.8333 Intermediate Similarity NPC166040
0.8333 Intermediate Similarity NPC476385
0.8323 Intermediate Similarity NPC476871
0.8323 Intermediate Similarity NPC158635
0.8323 Intermediate Similarity NPC229882
0.8323 Intermediate Similarity NPC114740
0.8322 Intermediate Similarity NPC89105
0.8322 Intermediate Similarity NPC64141
0.8322 Intermediate Similarity NPC68092
0.8322 Intermediate Similarity NPC476383
0.8322 Intermediate Similarity NPC472350
0.8322 Intermediate Similarity NPC81515
0.8322 Intermediate Similarity NPC156376
0.8322 Intermediate Similarity NPC197316
0.8312 Intermediate Similarity NPC478237
0.8312 Intermediate Similarity NPC93924
0.8311 Intermediate Similarity NPC177035
0.8311 Intermediate Similarity NPC52277
0.8311 Intermediate Similarity NPC199459
0.8302 Intermediate Similarity NPC226759
0.8302 Intermediate Similarity NPC187205

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC147224 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.882 High Similarity NPD7685 Pre-registration
0.8322 Intermediate Similarity NPD7266 Discontinued
0.8258 Intermediate Similarity NPD1653 Approved
0.7697 Intermediate Similarity NPD6653 Approved
0.7644 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD37 Approved
0.7605 Intermediate Similarity NPD7199 Phase 2
0.7588 Intermediate Similarity NPD7228 Approved
0.7576 Intermediate Similarity NPD4966 Approved
0.7576 Intermediate Similarity NPD4965 Approved
0.7576 Intermediate Similarity NPD4967 Phase 2
0.7547 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD3705 Approved
0.7516 Intermediate Similarity NPD6674 Discontinued
0.75 Intermediate Similarity NPD5762 Approved
0.75 Intermediate Similarity NPD5763 Approved
0.75 Intermediate Similarity NPD8127 Discontinued
0.7485 Intermediate Similarity NPD6234 Discontinued
0.7448 Intermediate Similarity NPD1357 Approved
0.7442 Intermediate Similarity NPD7054 Approved
0.7415 Intermediate Similarity NPD1091 Approved
0.7412 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD7472 Approved
0.7384 Intermediate Similarity NPD3818 Discontinued
0.7378 Intermediate Similarity NPD7028 Phase 2
0.7368 Intermediate Similarity NPD3027 Phase 3
0.7338 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD3620 Phase 2
0.7314 Intermediate Similarity NPD7240 Approved
0.7312 Intermediate Similarity NPD6190 Approved
0.7299 Intermediate Similarity NPD7074 Phase 3
0.7273 Intermediate Similarity NPD7808 Phase 3
0.7273 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD4140 Approved
0.7216 Intermediate Similarity NPD7251 Discontinued
0.72 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD5735 Approved
0.7159 Intermediate Similarity NPD6797 Phase 2
0.7143 Intermediate Similarity NPD8455 Phase 2
0.7124 Intermediate Similarity NPD2861 Phase 2
0.7118 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD1613 Approved
0.7105 Intermediate Similarity NPD6362 Approved
0.7089 Intermediate Similarity NPD7097 Phase 1
0.7081 Intermediate Similarity NPD1652 Phase 2
0.707 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD5124 Phase 1
0.7063 Intermediate Similarity NPD6005 Phase 3
0.7063 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD6004 Phase 3
0.7063 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD6002 Phase 3
0.7059 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD4110 Phase 3
0.7037 Intermediate Similarity NPD4628 Phase 3
0.7022 Intermediate Similarity NPD6559 Discontinued
0.7 Intermediate Similarity NPD3817 Phase 2
0.6993 Remote Similarity NPD3094 Phase 2
0.6972 Remote Similarity NPD1358 Approved
0.6962 Remote Similarity NPD6355 Discontinued
0.6959 Remote Similarity NPD5536 Phase 2
0.6951 Remote Similarity NPD5058 Phase 3
0.6949 Remote Similarity NPD5844 Phase 1
0.6948 Remote Similarity NPD5647 Approved
0.6944 Remote Similarity NPD8312 Approved
0.6944 Remote Similarity NPD8313 Approved
0.6928 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6928 Remote Similarity NPD6273 Approved
0.6923 Remote Similarity NPD7095 Approved
0.6918 Remote Similarity NPD5283 Phase 1
0.6901 Remote Similarity NPD3134 Approved
0.6899 Remote Similarity NPD4060 Phase 1
0.6897 Remote Similarity NPD228 Approved
0.6889 Remote Similarity NPD7549 Discontinued
0.6885 Remote Similarity NPD6842 Approved
0.6885 Remote Similarity NPD6841 Approved
0.6885 Remote Similarity NPD6843 Phase 3
0.6882 Remote Similarity NPD1934 Approved
0.6865 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6859 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6855 Remote Similarity NPD4340 Discontinued
0.6855 Remote Similarity NPD230 Phase 1
0.6854 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6852 Remote Similarity NPD1375 Discontinued
0.6848 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6845 Remote Similarity NPD3686 Approved
0.6845 Remote Similarity NPD3687 Approved
0.6832 Remote Similarity NPD7033 Discontinued
0.6829 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6825 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6824 Remote Similarity NPD7157 Approved
0.6813 Remote Similarity NPD6353 Approved
0.6802 Remote Similarity NPD5353 Approved
0.6795 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6795 Remote Similarity NPD5736 Approved
0.678 Remote Similarity NPD6166 Phase 2
0.678 Remote Similarity NPD6167 Clinical (unspecified phase)
0.678 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6776 Remote Similarity NPD3496 Discontinued
0.6771 Remote Similarity NPD7680 Approved
0.6766 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6765 Remote Similarity NPD4380 Phase 2
0.6753 Remote Similarity NPD5327 Phase 3
0.6753 Remote Similarity NPD2982 Phase 2
0.6753 Remote Similarity NPD2983 Phase 2
0.675 Remote Similarity NPD1933 Approved
0.675 Remote Similarity NPD3657 Discovery
0.675 Remote Similarity NPD447 Suspended
0.6744 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6744 Remote Similarity NPD2977 Approved
0.6744 Remote Similarity NPD2801 Approved
0.6744 Remote Similarity NPD2978 Approved
0.6742 Remote Similarity NPD7473 Discontinued
0.6735 Remote Similarity NPD7843 Approved
0.6732 Remote Similarity NPD422 Phase 1
0.6732 Remote Similarity NPD3092 Approved
0.6731 Remote Similarity NPD4624 Approved
0.673 Remote Similarity NPD6233 Phase 2
0.6727 Remote Similarity NPD8166 Discontinued
0.6724 Remote Similarity NPD7975 Clinical (unspecified phase)
0.6724 Remote Similarity NPD7075 Discontinued
0.6721 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6711 Remote Similarity NPD4626 Approved
0.6708 Remote Similarity NPD2492 Phase 1
0.6707 Remote Similarity NPD4357 Discontinued
0.6707 Remote Similarity NPD2424 Discontinued
0.6706 Remote Similarity NPD7458 Discontinued
0.6705 Remote Similarity NPD5402 Approved
0.6704 Remote Similarity NPD7799 Discontinued
0.6704 Remote Similarity NPD3751 Discontinued
0.6688 Remote Similarity NPD2981 Phase 2
0.6688 Remote Similarity NPD3018 Phase 2
0.6688 Remote Similarity NPD9494 Approved
0.6685 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6684 Remote Similarity NPD7296 Approved
0.6667 Remote Similarity NPD6232 Discontinued
0.6667 Remote Similarity NPD4237 Approved
0.6667 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4236 Phase 3
0.6667 Remote Similarity NPD5698 Clinical (unspecified phase)
0.6667 Remote Similarity NPD969 Suspended
0.6667 Remote Similarity NPD3882 Suspended
0.6648 Remote Similarity NPD5494 Approved
0.6647 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6647 Remote Similarity NPD7819 Suspended
0.6647 Remote Similarity NPD5563 Clinical (unspecified phase)
0.6647 Remote Similarity NPD1465 Phase 2
0.6646 Remote Similarity NPD4908 Phase 1
0.6645 Remote Similarity NPD5691 Approved
0.6628 Remote Similarity NPD6385 Approved
0.6628 Remote Similarity NPD6386 Approved
0.6627 Remote Similarity NPD6331 Phase 2
0.6627 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6627 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6626 Remote Similarity NPD4108 Discontinued
0.6625 Remote Similarity NPD6663 Approved
0.6624 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6606 Remote Similarity NPD970 Clinical (unspecified phase)
0.6603 Remote Similarity NPD8651 Approved
0.6601 Remote Similarity NPD5126 Approved
0.6601 Remote Similarity NPD5125 Phase 3
0.6598 Remote Similarity NPD7497 Discontinued
0.659 Remote Similarity NPD7945 Clinical (unspecified phase)
0.659 Remote Similarity NPD6801 Discontinued
0.6588 Remote Similarity NPD5403 Approved
0.6584 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6575 Remote Similarity NPD2684 Approved
0.6573 Remote Similarity NPD3787 Discontinued
0.6564 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6564 Remote Similarity NPD4538 Approved
0.6564 Remote Similarity NPD4536 Approved
0.6564 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6562 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6562 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6562 Remote Similarity NPD6798 Discontinued
0.6561 Remote Similarity NPD2797 Approved
0.6559 Remote Similarity NPD8434 Phase 2
0.6557 Remote Similarity NPD7039 Approved
0.6557 Remote Similarity NPD7038 Approved
0.6552 Remote Similarity NPD5760 Phase 2
0.6552 Remote Similarity NPD5773 Approved
0.6552 Remote Similarity NPD5772 Approved
0.6552 Remote Similarity NPD5761 Phase 2
0.655 Remote Similarity NPD4210 Discontinued
0.6538 Remote Similarity NPD4749 Approved
0.6536 Remote Similarity NPD5585 Approved
0.6531 Remote Similarity NPD7999 Approved
0.6524 Remote Similarity NPD5588 Approved
0.6522 Remote Similarity NPD1726 Clinical (unspecified phase)
0.6517 Remote Similarity NPD7930 Approved
0.6516 Remote Similarity NPD1610 Phase 2
0.6513 Remote Similarity NPD7435 Discontinued
0.6512 Remote Similarity NPD3866 Clinical (unspecified phase)
0.6509 Remote Similarity NPD1511 Approved
0.6507 Remote Similarity NPD290 Approved
0.6497 Remote Similarity NPD3225 Approved
0.6494 Remote Similarity NPD1778 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data